Clinical Trial Update: Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy [Phase 3]

View source ↗

Summary

This Phase 3 trial update investigates different cycles of capecitabine used with radiotherapy in stage II–III esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: The First Affiliated Hospital of Henan University of Science and Technology | Conditions: Stage III Esophageal Squamous Cell Carcinoma, Stage II Esophageal Squamous Cell Carcinoma | Phase 3 | Status: UNKNOWN